FIELD: chemistry of peptides, medicine, oncology, pharmaceutical chemistry.
SUBSTANCE: invention relates to the development of medicinal agent of peptide nature eliciting an antitumor effect and can be used in treatment of endocrine and hormone-dependent tumors. Agent represents peptide of the general formula: . Invention provides enhancement of the therapeutic effect and reducing toxicity.
EFFECT: valuable medicinal properties of agent.
3 cl, 4 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATING HORMONE-DEPENDENT TUMORS AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2703533C1 |
ANTICANCER DRUG FOR ORAL USE | 2020 |
|
RU2748989C1 |
3-OR-DI-(2-CHLOROETHYL)-AMINO-CONTAINING II α-ACYL-(HYDR)- -OXYSTEROIDS SHOWING ANTITUMOR ACTIVITY | 1998 |
|
RU2139292C1 |
NOVEL ANTITUMOR COMPOUNDS | 2003 |
|
RU2356908C2 |
PEPTIDE, POSSESSING ANTI-TUMOR AND ANTI-METASTATIC ACTIVITY, AND FINISHED DOSAGE FORM BASED THEREON | 2018 |
|
RU2682039C1 |
ANTITUMOR AGENT | 1999 |
|
RU2144821C1 |
PEPTIDE WITH ANTIPROLIFERATIVE ACTIVITY AND PHARMACEUTICAL COMPOSITION FOR TREATING PROLIFERATIVE DISEASES | 2007 |
|
RU2446174C2 |
DECAPEPTIDE SHOWING ANTITUMOR ACTIVITY | 1993 |
|
RU2084458C1 |
HIGHLY EFFECTIVE METHOD FOR PREPARING DOSAGE FORM OF TARGETED ACTION FOR THERAPY OF MALIGNANT GROWTHS | 2019 |
|
RU2727924C1 |
MEDICINAL AGENT FOR CANCER PREVENTION | 2006 |
|
RU2328294C1 |
Authors
Dates
2005-06-20—Published
2003-11-14—Filed